Lynsey Huxham
About Lynsey Huxham
Lynsey Huxham is a Senior Manager of Technology Licensing at AbCellera, with extensive experience in technology commercialization and market research. She holds a Ph.D. in Experimental Medicine and has a strong background in evaluating new technologies and developing therapeutics.
Work at AbCellera
Lynsey Huxham has served as Senior Manager, Technology Licensing at AbCellera since 2022. In this role, she focuses on the commercialization of technologies, leveraging her extensive background in market research and technology assessment. AbCellera is known for its innovative approach to antibody discovery and development, and Huxham's expertise in evaluating the potential and value of new technologies contributes to the company's mission in the biotechnology sector.
Education and Expertise
Lynsey Huxham holds a B.Sc. in Cell Biology and Genetics, an M.Sc. in Chemistry, and a Ph.D. in Experimental Medicine, all from The University of British Columbia. Her educational background provides her with a strong foundation in biological sciences and technology commercialization. Huxham possesses skills in IP and technology assessment, patent drafting, and prosecution, which are essential for navigating the complexities of technology licensing and commercialization.
Background
Lynsey Huxham has a diverse professional background, beginning her career as a Research Assistant at The University of British Columbia from 2001 to 2002. She then worked at the BC Cancer Agency from 2002 to 2003 before returning to The University of British Columbia as a Technology Transfer Manager from 2007 to 2021. This extensive experience in research and technology transfer has equipped her with a comprehensive understanding of in vivo models of disease and drug development processes.
Achievements
Throughout her career, Lynsey Huxham has specialized in the development and commercialization of small molecules and biological therapeutics. She has a strong background in designing in vitro assays and is experienced in immunohistochemistry. Her work has contributed to advancements in disease research and therapeutic development, showcasing her commitment to the field of biotechnology.